Israel
# |
Name |
Free Cash Flow |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD -6.14 M
|
Dec. 31, 2023 | USD 2.82 | -2.08% |
|
Israel |
|
2 |
USD -6.69 M
|
Dec. 31, 2023 | USD 2.74 | -3.52% |
|
Israel |
|
3 |
USD -7.33 M
|
Dec. 31, 2023 | USD 2.36 | -1.67% |
|
Israel |
|
4 |
USD -8.44 M
|
Dec. 31, 2023 | USD 0.01 | 0.04% |
|
Israel |
|
5 |
USD -8.48 M
|
Dec. 31, 2023 | USD 1.03 | -0.96% |
|
Israel |
|
6 |
USD -19.93 M
|
Dec. 31, 2023 | USD 0.02 | -1.36% |
|
Israel |
|
7 |
USD -22.91 M
|
Dec. 31, 2023 | USD 0.01 | -11.50% |
|
Israel |
|
8 |
USD -23.61 M
|
Dec. 31, 2023 | USD 1.90 | -4.04% |
|
Israel |
|
9 |
USD -23.76 M
|
Dec. 31, 2023 | USD 1.16 | -2.88% |
|
Israel |
|
10 |
USD -24.36 M
|
Dec. 31, 2023 | USD 4.00 | 8.11% |
|
Israel |
|
11 |
USD -36.06 M
|
Dec. 31, 2023 | USD 1.85 | 10.75% |
|
Israel |
The Clinical Trials company in Israel with the highest Free Cash Flow is Galmed Pharmaceuticals Ltd. (NasdaqCM: GLMD) at USD -6.14 M.
The Clinical Trials company in Israel with the lowest Free Cash Flow is Compugen Ltd. (Tel Aviv Stock Exchange: CGEN.TA) at USD -36.06 M.
The top 10 Clinical Trials companies in Israel by Free Cash Flow are Galmed Pharmaceuticals Ltd., PainReform Ltd., Entera Bio Ltd., Can-Fite BioPharma Ltd., NeuroSense Therapeutics Ltd., Purple Biotech Ltd., BioLineRx Ltd., Chemomab Therapeutics Ltd., Enlivex Therapeutics Ltd. and Alpha Tau Medical Ltd..
The bottom 10 Clinical Trials companies in Israel by Free Cash Flow are Compugen Ltd., Alpha Tau Medical Ltd., Enlivex Therapeutics Ltd., Chemomab Therapeutics Ltd., BioLineRx Ltd., Purple Biotech Ltd., NeuroSense Therapeutics Ltd., Can-Fite BioPharma Ltd., Entera Bio Ltd. and PainReform Ltd..